These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32096041)

  • 21. Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective.
    Ricci M; Cimini A; Camedda R; Chiaravalloti A; Schillaci O
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer's disease and other tauopathies.
    Gabellieri E; Capotosti F; Molette J; Sreenivasachary N; Mueller A; Berndt M; Schieferstein H; Juergens T; Varisco Y; Oden F; Schmitt-Willich H; Hickman D; Dinkelborg L; Stephens A; Pfeifer A; Kroth H
    Eur J Med Chem; 2020 Oct; 204():112615. PubMed ID: 32771872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET imaging of tau protein targets: a methodology perspective.
    Lois C; Gonzalez I; Johnson KA; Price JC
    Brain Imaging Behav; 2019 Apr; 13(2):333-344. PubMed ID: 29497982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of tau PET molecular imaging.
    Cassinelli Petersen G; Roytman M; Chiang GC; Li Y; Gordon ML; Franceschi AM
    Curr Opin Neurol; 2022 Apr; 35(2):230-239. PubMed ID: 35191407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical Evaluation of
    Honer M; Gobbi L; Knust H; Kuwabara H; Muri D; Koerner M; Valentine H; Dannals RF; Wong DF; Borroni E
    J Nucl Med; 2018 Apr; 59(4):675-681. PubMed ID: 28970331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease.
    Yap SY; Frias B; Wren MC; Schöll M; Fox NC; Årstad E; Lashley T; Sander K
    Brain; 2021 Sep; 144(8):2284-2290. PubMed ID: 33742656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.
    Ono M; Sahara N; Kumata K; Ji B; Ni R; Koga S; Dickson DW; Trojanowski JQ; Lee VM; Yoshida M; Hozumi I; Yoshiyama Y; van Swieten JC; Nordberg A; Suhara T; Zhang MR; Higuchi M
    Brain; 2017 Mar; 140(3):764-780. PubMed ID: 28087578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro evaluation of [
    Varlow C; Mathis CA; Vasdev N
    Nucl Med Biol; 2024; 130-131():108891. PubMed ID: 38458074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tau Positron Emission Tomography Imaging.
    Kolb HC; Andrés JI
    Cold Spring Harb Perspect Biol; 2017 May; 9(5):. PubMed ID: 27940517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET.
    Mohammadi Z; Alizadeh H; Marton J; Cumming P
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head-to-head comparison of [
    Aguero C; Dhaynaut M; Amaral AC; Moon SH; Neelamegam R; Scapellato M; Carazo-Casas C; Kumar S; El Fakhri G; Johnson K; Frosch MP; Normandin MD; Gómez-Isla T
    Acta Neuropathol; 2024 Jan; 147(1):25. PubMed ID: 38280071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau Fibrils.
    Zhou Y; Li J; Nordberg A; Ågren H
    ACS Chem Neurosci; 2021 Sep; 12(18):3487-3496. PubMed ID: 34464084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Machine Learning-Based Approach to Discrimination of Tauopathies Using [
    Endo H; Tagai K; Ono M; Ikoma Y; Oyama A; Matsuoka K; Kokubo N; Hirata K; Sano Y; Oya M; Matsumoto H; Kurose S; Seki C; Shimizu H; Kakita A; Takahata K; Shinotoh H; Shimada H; Tokuda T; Kawamura K; Zhang MR; Oishi K; Mori S; Takado Y; Higuchi M
    Mov Disord; 2022 Nov; 37(11):2236-2246. PubMed ID: 36054492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
    J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of 3 Novel Tau Radiopharmaceuticals,
    Wong DF; Comley RA; Kuwabara H; Rosenberg PB; Resnick SM; Ostrowitzki S; Vozzi C; Boess F; Oh E; Lyketsos CG; Honer M; Gobbi L; Klein G; George N; Gapasin L; Kitzmiller K; Roberts J; Sevigny J; Nandi A; Brasic J; Mishra C; Thambisetty M; Mogekar A; Mathur A; Albert M; Dannals RF; Borroni E
    J Nucl Med; 2018 Dec; 59(12):1869-1876. PubMed ID: 29728519
    [No Abstract]   [Full Text] [Related]  

  • 36. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
    Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
    Mol Psychiatry; 2018 Jul; 23(7):1666-1673. PubMed ID: 28507319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography.
    Wang YT; Edison P
    Curr Neurol Neurosci Rep; 2019 Jun; 19(7):45. PubMed ID: 31172290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
    Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the In Vivo Relationship Between Cerebral Hypometabolism, Tau Deposition, TSPO Expression, and Synaptic Density in a Tauopathy Mouse Model: a Multi-tracer PET Study.
    Endepols H; Anglada-Huguet M; Mandelkow E; Schmidt Y; Krapf P; Zlatopolskiy BD; Neumaier B; Mandelkow EM; Drzezga A
    Mol Neurobiol; 2022 Jun; 59(6):3402-3413. PubMed ID: 35312967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond the Amyloid Hypothesis of Alzheimer's Disease: Tau Pathology Takes Center Stage.
    ACS Chem Neurosci; 2018 Nov; 9(11):2519. PubMed ID: 30458619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.